|
|
| Line 1: |
Line 1: |
| [[Image:3b5h.jpg|left|200px]] | | {{Seed}} |
| | [[Image:3b5h.png|left|200px]] |
|
| |
|
| <!-- | | <!-- |
| Line 9: |
Line 10: |
| {{STRUCTURE_3b5h| PDB=3b5h | SCENE= }} | | {{STRUCTURE_3b5h| PDB=3b5h | SCENE= }} |
|
| |
|
| '''Crystal structure of the extracellular portion of HAb18G/CD147'''
| | ===Crystal structure of the extracellular portion of HAb18G/CD147=== |
|
| |
|
|
| |
|
| ==Overview==
| | <!-- |
| CD147, a member of the immunoglobulin superfamily (IgSF), plays fundamental roles in intercellular interactions in numerous pathological and physiological processes. Importantly, our previous studies have demonstrated that HAb18G/CD147 is a novel hepatocellular carcinoma (HCC)- associated antigen and HAb18G/CD147 stimulates adjacent fibroblasts and HCC cells to produce elevated levels of several matrix metalloproteinases (MMPs), facilitating invasion and metastasis of the HCC cells. In addition, HAb18G/CD147 has also been shown to be a novel universal cancer biomarker for diagnosis and prognostic assessment of a wide range of cancers. However, the structural basis underlying the multifunctional character of CD147 remains unresolved. We report here the crystal structure of the extracellular portion of HAb18G/CD147 at 2.8 A resolution. The structure comprises an N-terminal IgC2 domain and a C-terminal IgI domain, which are connected by a 5-residue flexible linker. This unique C2-I domain organization is distinct from those of other IgSF members. Four homophilic dimers exist in the crystal and adopt C2-C2 and C2-I dimerization rather than V-V dimerization commonly found in other IgSF members. This type of homophilic association thus presents a novel model for homophilic interaction between C2 domains of IgSF members. Moreover, the crystal structure of HAb18G/CD147 provides a good structural explanation for the established multifunction of CD147 mediated by homo/hetero-oligomerizations, and should represent a general architecture of other CD147 family members. The information derived from the structure may also facilitate the structure-based rational drug design and provide some novel insights into the structure-function relationship for IgSF molecules.
| | The line below this paragraph, {{ABSTRACT_PUBMED_18430721}}, adds the Publication Abstract to the page |
| | (as it appears on PubMed at http://www.pubmed.gov), where 18430721 is the PubMed ID number. |
| | --> |
| | {{ABSTRACT_PUBMED_18430721}} |
|
| |
|
| ==Disease== | | ==Disease== |
| Line 29: |
Line 33: |
| [[Category: Cell invasion]] | | [[Category: Cell invasion]] |
| [[Category: Ig-like domain]] | | [[Category: Ig-like domain]] |
| ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Wed May 7 08:52:42 2008'' | | |
| | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Wed Jul 9 10:09:35 2008'' |